Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000559709 | SCV000622236 | pathogenic | Ataxia-telangiectasia syndrome | 2017-04-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, loss-of-function variants in ATM are known to be pathogenic (PMID: 25614872, 23807571). This sequence change creates a premature translational stop signal at codon 380 (p.Tyr380*) of the ATM gene. It is expected to result in an absent or disrupted protein product. |
Myriad Genetics, |
RCV004023629 | SCV004931660 | pathogenic | Familial cancer of breast | 2024-01-12 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |